MYMariam Youssef

Mariam Youssef

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mariam Youssef has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Diffuse Large B‐Cell Lymphoma of the Uterine Corpus Presenting With Abnormal Uterine Bleeding: An Unusual Presentation and Review of the Literature

    by Yomna Amer, Gopal Kumar, Gunja Piya, Fnu Raja, Chandini Madeswaran, Rania Rayes-Danan, Yan Wang, Salman Ayub, Mariam Youssef

    Diffuse large B‐cell lymphoma (DLBCL) is an aggressive form of non‐Hodgkin lymphoma. Lymphomas involving the female genital system are exceedingly rare, comprising approximately 1% of extranodal lymphomas, with DLBCL being the most prevalent type. Here, we report a rare case of endometrial involvement by DLBCL in a middle‐aged female who presented with abnormal uterine bleeding and fatigue over 3 weeks. Laboratory findings revealed severe anemia, while pelvic ultrasound demonstrated a thickened endometrium, a 1.6‐cm hypoechoic uterine lesion, and multiple enlarged bilateral adnexal lymph nodes. Histological evaluation of an endometrial biopsy revealed diffuse subepithelial proliferation of large, poorly differentiated round cells with finely dispersed chromatin, inconspicuous nucleoli, and moderate cytoplasm. Initial immunohistochemical staining excluded primary epithelial or mesenchymal uterine tumors, showing positivity for CD45. Further workup confirmed CD20 positivity, leading to a diagnosis of DLBCL with a nongerminal center, double‐expressor phenotype. Radiological imaging identified diffuse lymphadenopathy with pulmonary and renal nodules, consistent with Stage IV DLBCL. Given its rarity and morphological overlap, uterine lymphoma may mimic poorly differentiated uterine malignancies, such as dedifferentiated/undifferentiated carcinomas or endometrial stromal sarcomas, especially on small biopsies. Thus, incorporating lymphoma lineage markers is essential for accurate diagnosis. The patient was treated with six cycles of the R‐CHOP regimen, initially achieving a complete metabolic response. However, she was recently admitted for central nervous system (CNS) relapse and restarted chemotherapy.

  • Open Access

    CALFAN (Low γ-Glutamyl Transpeptidase (GGT) Cholestasis, Acute Liver Failure, and Neurodegeneration) Syndrome: A Case Report with 3-Year Follow-Up after Liver Transplantation in Early Adulthood

    by Mariam Youssef, Katherine L. Mascia, Brendan McGuire, Chirag R. Patel, Sameer Al Diffalha, Deepti Dhall, Goo Lee

    CALFAN syndrome is an extremely rare disease consisting of recurrent pediatric acute liver failure (PALF), neurodegenerative diseases, and skeletal abnormalities associated with SCYL1 gene mutation. To date, three of 18 patients reported underwent liver transplantation in infancy and early childhood (723months). Here, we report a case of CALFAN syndrome with infantile onset, recurrent jaundice/PALF requiring liver transplantation in early adulthood. At the most recent follow-up, 3years after transplantation, the patient is doing well.